Concepts (290)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dendritic Cells | 18 | 2021 | 143 | 4.760 |
Why?
|
| Toll-Like Receptor 4 | 12 | 2021 | 70 | 4.170 |
Why?
|
| Pulmonary Surfactant-Associated Protein A | 10 | 2021 | 23 | 3.710 |
Why?
|
| Peptide Fragments | 6 | 2021 | 202 | 2.930 |
Why?
|
| Lipopolysaccharides | 8 | 2022 | 156 | 2.260 |
Why?
|
| Coccidioidomycosis | 7 | 2019 | 13 | 1.880 |
Why?
|
| Coccidioides | 8 | 2019 | 14 | 1.790 |
Why?
|
| Pneumonia | 4 | 2021 | 89 | 1.350 |
Why?
|
| Glycoproteins | 5 | 2019 | 122 | 1.320 |
Why?
|
| Lung | 9 | 2022 | 376 | 1.280 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2021 | 126 | 1.280 |
Why?
|
| Piperidones | 4 | 2019 | 32 | 1.240 |
Why?
|
| Fungal Vaccines | 3 | 2017 | 8 | 1.150 |
Why?
|
| Animals | 36 | 2022 | 10416 | 1.040 |
Why?
|
| Mice | 23 | 2022 | 4655 | 1.010 |
Why?
|
| Fungal Proteins | 3 | 2019 | 82 | 0.870 |
Why?
|
| Pulmonary Surfactant-Associated Protein D | 5 | 2022 | 8 | 0.850 |
Why?
|
| Transfection | 4 | 2017 | 318 | 0.840 |
Why?
|
| Benzylidene Compounds | 3 | 2019 | 29 | 0.830 |
Why?
|
| Inflammation | 2 | 2021 | 633 | 0.770 |
Why?
|
| Receptors, Interleukin-1 | 2 | 2019 | 12 | 0.760 |
Why?
|
| Lung Injury | 1 | 2022 | 32 | 0.760 |
Why?
|
| Antigens, Fungal | 2 | 2019 | 6 | 0.750 |
Why?
|
| Inflammation Mediators | 3 | 2019 | 165 | 0.740 |
Why?
|
| Immunization | 3 | 2019 | 120 | 0.720 |
Why?
|
| Lung Diseases | 3 | 2011 | 43 | 0.700 |
Why?
|
| Phagocytosis | 5 | 2019 | 80 | 0.690 |
Why?
|
| Mice, Inbred C57BL | 9 | 2021 | 1573 | 0.660 |
Why?
|
| Interleukin-1 Receptor-Like 1 Protein | 1 | 2019 | 3 | 0.650 |
Why?
|
| Disease Models, Animal | 9 | 2022 | 1462 | 0.620 |
Why?
|
| Papio | 4 | 2008 | 79 | 0.620 |
Why?
|
| Pneumonia, Bacterial | 1 | 2019 | 18 | 0.610 |
Why?
|
| Pseudomonas Infections | 1 | 2019 | 25 | 0.610 |
Why?
|
| Disease Susceptibility | 4 | 2010 | 74 | 0.590 |
Why?
|
| Host-Pathogen Interactions | 1 | 2019 | 91 | 0.580 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2019 | 71 | 0.570 |
Why?
|
| Cell Line | 6 | 2021 | 694 | 0.560 |
Why?
|
| Immunophenotyping | 4 | 2017 | 60 | 0.550 |
Why?
|
| Vaccines, DNA | 1 | 2017 | 11 | 0.530 |
Why?
|
| Bone Marrow Cells | 3 | 2012 | 80 | 0.500 |
Why?
|
| Inflammasomes | 1 | 2015 | 19 | 0.480 |
Why?
|
| Papio anubis | 3 | 2011 | 48 | 0.480 |
Why?
|
| Adenosine Triphosphate | 1 | 2015 | 118 | 0.470 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2011 | 248 | 0.460 |
Why?
|
| Pulmonary Surfactants | 4 | 2010 | 11 | 0.460 |
Why?
|
| Protein Binding | 4 | 2021 | 657 | 0.450 |
Why?
|
| Helicobacter pylori | 3 | 2003 | 18 | 0.450 |
Why?
|
| Pentetic Acid | 1 | 2014 | 4 | 0.440 |
Why?
|
| Curcumin | 2 | 2014 | 69 | 0.430 |
Why?
|
| Carrier Proteins | 1 | 2015 | 252 | 0.420 |
Why?
|
| Cells, Cultured | 8 | 2019 | 985 | 0.420 |
Why?
|
| Cytokines | 6 | 2021 | 446 | 0.420 |
Why?
|
| Shock, Septic | 1 | 2013 | 38 | 0.400 |
Why?
|
| Amino Acid Sequence | 4 | 2021 | 690 | 0.390 |
Why?
|
| Interleukin-12 | 3 | 2010 | 19 | 0.380 |
Why?
|
| Female | 12 | 2021 | 15192 | 0.370 |
Why?
|
| Shock, Hemorrhagic | 3 | 2016 | 48 | 0.350 |
Why?
|
| Toll-Like Receptor 2 | 2 | 2008 | 30 | 0.340 |
Why?
|
| Helicobacter Infections | 2 | 2003 | 17 | 0.330 |
Why?
|
| Immunologic Factors | 1 | 2010 | 49 | 0.330 |
Why?
|
| Fetus | 2 | 2008 | 77 | 0.320 |
Why?
|
| Hemoglobins | 3 | 2016 | 118 | 0.320 |
Why?
|
| Bronchoalveolar Lavage Fluid | 3 | 2004 | 25 | 0.320 |
Why?
|
| Anti-Bacterial Agents | 1 | 2014 | 523 | 0.310 |
Why?
|
| Papio cynocephalus | 1 | 2009 | 5 | 0.310 |
Why?
|
| Anti-Infective Agents | 1 | 2010 | 80 | 0.310 |
Why?
|
| NF-kappa B | 4 | 2019 | 191 | 0.290 |
Why?
|
| Candidiasis | 1 | 2008 | 25 | 0.290 |
Why?
|
| Cell Survival | 2 | 2021 | 408 | 0.280 |
Why?
|
| Humans | 18 | 2022 | 28168 | 0.280 |
Why?
|
| Bacterial Infections | 1 | 2008 | 58 | 0.280 |
Why?
|
| Gene Expression Regulation | 5 | 2021 | 633 | 0.270 |
Why?
|
| HEK293 Cells | 2 | 2021 | 187 | 0.270 |
Why?
|
| Recombinant Proteins | 2 | 2010 | 414 | 0.270 |
Why?
|
| Antibodies, Fungal | 2 | 2019 | 9 | 0.240 |
Why?
|
| Lung Diseases, Fungal | 1 | 2004 | 14 | 0.230 |
Why?
|
| Signal Transduction | 5 | 2019 | 1433 | 0.230 |
Why?
|
| Molecular Sequence Data | 3 | 2013 | 1052 | 0.220 |
Why?
|
| Receptors, Immunologic | 1 | 2004 | 72 | 0.220 |
Why?
|
| Administration, Intranasal | 2 | 2017 | 12 | 0.220 |
Why?
|
| Gastritis | 1 | 2003 | 3 | 0.220 |
Why?
|
| Stomach Ulcer | 1 | 2003 | 6 | 0.210 |
Why?
|
| Mutation | 2 | 2021 | 849 | 0.210 |
Why?
|
| Plasmids | 2 | 2017 | 125 | 0.210 |
Why?
|
| Indicators and Reagents | 1 | 2003 | 26 | 0.210 |
Why?
|
| Flow Cytometry | 3 | 2011 | 288 | 0.210 |
Why?
|
| Cytotoxins | 1 | 2003 | 51 | 0.210 |
Why?
|
| Adenosine Triphosphatases | 1 | 2003 | 49 | 0.210 |
Why?
|
| Proteolipids | 2 | 2001 | 4 | 0.210 |
Why?
|
| RNA, Messenger | 4 | 2015 | 658 | 0.210 |
Why?
|
| Choline-Phosphate Cytidylyltransferase | 2 | 2001 | 2 | 0.190 |
Why?
|
| Liposomes | 2 | 2016 | 145 | 0.190 |
Why?
|
| Escherichia coli | 3 | 2011 | 336 | 0.190 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2019 | 80 | 0.190 |
Why?
|
| Transgenes | 2 | 2013 | 63 | 0.190 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2001 | 87 | 0.190 |
Why?
|
| Colitis | 2 | 2012 | 54 | 0.190 |
Why?
|
| Phospholipases A | 1 | 2001 | 6 | 0.180 |
Why?
|
| Arachidonate 5-Lipoxygenase | 1 | 2001 | 12 | 0.180 |
Why?
|
| Ceramides | 1 | 2001 | 24 | 0.180 |
Why?
|
| Cytosol | 1 | 2001 | 47 | 0.180 |
Why?
|
| Protein Kinase C | 1 | 2001 | 73 | 0.180 |
Why?
|
| Isoenzymes | 1 | 2001 | 86 | 0.180 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2001 | 11 | 0.180 |
Why?
|
| Mice, Inbred BALB C | 3 | 2013 | 276 | 0.170 |
Why?
|
| Animals, Newborn | 3 | 2011 | 180 | 0.160 |
Why?
|
| Interleukin-33 | 1 | 2019 | 5 | 0.160 |
Why?
|
| Peptides | 1 | 2022 | 289 | 0.160 |
Why?
|
| Sp1 Transcription Factor | 1 | 2019 | 17 | 0.160 |
Why?
|
| Intestinal Mucosa | 3 | 2016 | 197 | 0.160 |
Why?
|
| Bacterial Load | 1 | 2019 | 6 | 0.150 |
Why?
|
| Phagosomes | 1 | 2019 | 6 | 0.150 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 1999 | 47 | 0.150 |
Why?
|
| Antigens, Bacterial | 2 | 2012 | 161 | 0.150 |
Why?
|
| Up-Regulation | 1 | 2019 | 245 | 0.150 |
Why?
|
| Immunoglobulin G | 1 | 2020 | 270 | 0.150 |
Why?
|
| DNA, Complementary | 2 | 2010 | 77 | 0.150 |
Why?
|
| Lymphocytes | 1 | 2019 | 91 | 0.150 |
Why?
|
| Spleen | 2 | 2010 | 112 | 0.140 |
Why?
|
| Infant, Newborn | 3 | 2011 | 890 | 0.140 |
Why?
|
| Plasma Substitutes | 1 | 2016 | 5 | 0.130 |
Why?
|
| Proteostasis Deficiencies | 1 | 2016 | 5 | 0.130 |
Why?
|
| Ileum | 1 | 2016 | 25 | 0.130 |
Why?
|
| Nanotechnology | 1 | 2016 | 68 | 0.120 |
Why?
|
| Resuscitation | 1 | 2016 | 59 | 0.120 |
Why?
|
| Peptic Ulcer | 1 | 1995 | 11 | 0.120 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2015 | 15 | 0.120 |
Why?
|
| Interleukin-1beta | 1 | 2015 | 43 | 0.120 |
Why?
|
| Gene Expression | 1 | 2017 | 416 | 0.120 |
Why?
|
| Cell Line, Transformed | 2 | 2012 | 42 | 0.110 |
Why?
|
| Dimerization | 1 | 2014 | 76 | 0.110 |
Why?
|
| Mice, Inbred C3H | 2 | 2011 | 74 | 0.110 |
Why?
|
| Escherichia coli Infections | 2 | 2011 | 45 | 0.100 |
Why?
|
| Phenotype | 2 | 2006 | 679 | 0.100 |
Why?
|
| Protein Interaction Maps | 1 | 2013 | 11 | 0.100 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2012 | 11 | 0.100 |
Why?
|
| Colony Count, Microbial | 2 | 2010 | 81 | 0.100 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2012 | 15 | 0.100 |
Why?
|
| Respiratory Tract Infections | 1 | 2012 | 39 | 0.100 |
Why?
|
| Survival Analysis | 2 | 2010 | 289 | 0.100 |
Why?
|
| Immunohistochemistry | 2 | 2006 | 463 | 0.100 |
Why?
|
| Hyperplasia | 1 | 2011 | 27 | 0.090 |
Why?
|
| Macrophages | 2 | 2012 | 296 | 0.090 |
Why?
|
| Mucous Membrane | 1 | 2011 | 27 | 0.090 |
Why?
|
| Biological Products | 1 | 2012 | 65 | 0.090 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2011 | 15 | 0.090 |
Why?
|
| Anthrax | 1 | 2012 | 89 | 0.090 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2012 | 77 | 0.090 |
Why?
|
| Enterococcus faecalis | 1 | 2012 | 71 | 0.090 |
Why?
|
| Bacteria | 1 | 2014 | 282 | 0.090 |
Why?
|
| Colonic Neoplasms | 1 | 2012 | 122 | 0.090 |
Why?
|
| Bacillus anthracis | 1 | 2012 | 151 | 0.090 |
Why?
|
| Interferon-gamma | 2 | 2016 | 107 | 0.090 |
Why?
|
| Arabinofuranosyluracil | 1 | 2010 | 3 | 0.090 |
Why?
|
| Thymidine Kinase | 1 | 2010 | 6 | 0.090 |
Why?
|
| Cell Shape | 1 | 2010 | 16 | 0.090 |
Why?
|
| Microscopy, Confocal | 1 | 2011 | 113 | 0.090 |
Why?
|
| Biofilms | 1 | 2012 | 121 | 0.090 |
Why?
|
| Pulmonary Surfactant-Associated Proteins | 2 | 2001 | 2 | 0.080 |
Why?
|
| Tissue Distribution | 1 | 2010 | 137 | 0.080 |
Why?
|
| Molecular Imaging | 1 | 2010 | 35 | 0.080 |
Why?
|
| Patents as Topic | 1 | 2010 | 5 | 0.080 |
Why?
|
| Immunologic Memory | 1 | 2010 | 58 | 0.080 |
Why?
|
| Models, Animal | 1 | 2010 | 128 | 0.080 |
Why?
|
| Surface-Active Agents | 1 | 2010 | 44 | 0.080 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2010 | 96 | 0.080 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2010 | 105 | 0.080 |
Why?
|
| Respiration, Artificial | 2 | 2001 | 42 | 0.080 |
Why?
|
| Mice, Knockout | 2 | 2010 | 847 | 0.080 |
Why?
|
| Epitopes | 1 | 2010 | 179 | 0.080 |
Why?
|
| Infant, Premature | 1 | 2011 | 141 | 0.080 |
Why?
|
| Lymphocyte Activation | 1 | 2010 | 208 | 0.080 |
Why?
|
| Bacterial Toxins | 1 | 2012 | 267 | 0.080 |
Why?
|
| Phospholipids | 1 | 2009 | 76 | 0.080 |
Why?
|
| CD11c Antigen | 1 | 2009 | 10 | 0.080 |
Why?
|
| B7-2 Antigen | 1 | 2009 | 8 | 0.080 |
Why?
|
| B7-1 Antigen | 1 | 2009 | 11 | 0.080 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2009 | 26 | 0.080 |
Why?
|
| CD40 Antigens | 1 | 2009 | 14 | 0.080 |
Why?
|
| Cell Separation | 1 | 2009 | 55 | 0.080 |
Why?
|
| Cell Lineage | 1 | 2009 | 51 | 0.080 |
Why?
|
| Immunity, Innate | 2 | 2008 | 225 | 0.080 |
Why?
|
| Virulence | 2 | 2012 | 151 | 0.080 |
Why?
|
| Hot Temperature | 1 | 2009 | 87 | 0.070 |
Why?
|
| Sequence Alignment | 1 | 2008 | 111 | 0.070 |
Why?
|
| Bacterial Capsules | 1 | 2007 | 9 | 0.070 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2007 | 12 | 0.070 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2007 | 13 | 0.070 |
Why?
|
| Gestational Age | 1 | 2008 | 146 | 0.070 |
Why?
|
| Microbiological Techniques | 1 | 2007 | 8 | 0.070 |
Why?
|
| Cell Differentiation | 2 | 2012 | 407 | 0.070 |
Why?
|
| Age Factors | 1 | 2009 | 733 | 0.070 |
Why?
|
| Escherichia coli K12 | 1 | 2006 | 4 | 0.060 |
Why?
|
| Cell-Free System | 1 | 2006 | 21 | 0.060 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2006 | 17 | 0.060 |
Why?
|
| Interleukin-4 | 1 | 2006 | 23 | 0.060 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2006 | 19 | 0.060 |
Why?
|
| Indium Radioisotopes | 1 | 2005 | 7 | 0.060 |
Why?
|
| Adoptive Transfer | 1 | 2005 | 25 | 0.060 |
Why?
|
| Radionuclide Imaging | 1 | 2005 | 56 | 0.060 |
Why?
|
| Th1 Cells | 1 | 2005 | 36 | 0.060 |
Why?
|
| T-Lymphocytes | 1 | 2007 | 283 | 0.060 |
Why?
|
| Immunotherapy | 1 | 2007 | 158 | 0.060 |
Why?
|
| Male | 5 | 2016 | 13511 | 0.060 |
Why?
|
| Mice, Inbred DBA | 1 | 2004 | 30 | 0.060 |
Why?
|
| Phosphatidylcholines | 2 | 2001 | 45 | 0.060 |
Why?
|
| Rats | 3 | 2016 | 1568 | 0.050 |
Why?
|
| Pyloric Antrum | 1 | 2003 | 21 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2016 | 544 | 0.050 |
Why?
|
| Membrane Proteins | 2 | 2012 | 485 | 0.050 |
Why?
|
| Adaptation, Physiological | 1 | 2004 | 169 | 0.050 |
Why?
|
| Child | 2 | 2003 | 2253 | 0.050 |
Why?
|
| Viruses | 1 | 2003 | 19 | 0.050 |
Why?
|
| HeLa Cells | 1 | 2003 | 208 | 0.050 |
Why?
|
| Cation Transport Proteins | 1 | 2003 | 60 | 0.050 |
Why?
|
| Biopsy | 1 | 2003 | 207 | 0.050 |
Why?
|
| Adolescent | 2 | 2003 | 3128 | 0.050 |
Why?
|
| Chronic Disease | 2 | 2000 | 274 | 0.050 |
Why?
|
| Leukotrienes | 1 | 2001 | 1 | 0.050 |
Why?
|
| Lysophosphatidylcholines | 1 | 2001 | 4 | 0.050 |
Why?
|
| Protein Kinase C-alpha | 1 | 2001 | 9 | 0.050 |
Why?
|
| Phospholipases A2 | 1 | 2001 | 9 | 0.050 |
Why?
|
| Eicosanoids | 1 | 2001 | 10 | 0.050 |
Why?
|
| Genes, Dominant | 1 | 2001 | 35 | 0.050 |
Why?
|
| Phosphates | 1 | 2001 | 31 | 0.050 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2001 | 45 | 0.050 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2001 | 23 | 0.050 |
Why?
|
| Immunocompromised Host | 1 | 2021 | 28 | 0.050 |
Why?
|
| Research Report | 1 | 2021 | 23 | 0.050 |
Why?
|
| Cyclooxygenase 2 | 1 | 2001 | 68 | 0.040 |
Why?
|
| Bronchopneumonia | 1 | 2001 | 1 | 0.040 |
Why?
|
| Consensus | 1 | 2021 | 75 | 0.040 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2001 | 21 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2001 | 315 | 0.040 |
Why?
|
| Critical Illness | 1 | 2021 | 68 | 0.040 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2000 | 6 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2001 | 578 | 0.040 |
Why?
|
| Blotting, Northern | 1 | 1999 | 46 | 0.040 |
Why?
|
| In Situ Hybridization | 1 | 1999 | 34 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1999 | 258 | 0.040 |
Why?
|
| Analysis of Variance | 1 | 1999 | 390 | 0.040 |
Why?
|
| Adult | 2 | 2003 | 7765 | 0.040 |
Why?
|
| Blotting, Western | 1 | 1999 | 513 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2003 | 2558 | 0.030 |
Why?
|
| Pregnancy | 1 | 2001 | 1191 | 0.030 |
Why?
|
| Unfolded Protein Response | 1 | 2016 | 25 | 0.030 |
Why?
|
| Ubiquitination | 1 | 2016 | 32 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2016 | 38 | 0.030 |
Why?
|
| Drug Resistance, Microbial | 1 | 1995 | 36 | 0.030 |
Why?
|
| Metronidazole | 1 | 1995 | 16 | 0.030 |
Why?
|
| Oxidative Stress | 2 | 2016 | 663 | 0.030 |
Why?
|
| Bacterial Typing Techniques | 1 | 1995 | 125 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 1995 | 148 | 0.030 |
Why?
|
| United States | 1 | 2021 | 2151 | 0.030 |
Why?
|
| Solubility | 1 | 2012 | 73 | 0.020 |
Why?
|
| Receptors, Peptide | 1 | 2012 | 20 | 0.020 |
Why?
|
| Mixed Function Oxygenases | 1 | 2012 | 19 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2012 | 62 | 0.020 |
Why?
|
| Muscle Proteins | 1 | 2012 | 56 | 0.020 |
Why?
|
| Actins | 1 | 2012 | 96 | 0.020 |
Why?
|
| Nanoparticles | 1 | 2016 | 288 | 0.020 |
Why?
|
| Microbial Viability | 1 | 2012 | 29 | 0.020 |
Why?
|
| Time Factors | 1 | 2016 | 1593 | 0.020 |
Why?
|
| Citrobacter rodentium | 1 | 2011 | 1 | 0.020 |
Why?
|
| Peroxidase | 1 | 2011 | 39 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2012 | 86 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2012 | 386 | 0.020 |
Why?
|
| Diet | 1 | 2011 | 232 | 0.020 |
Why?
|
| Calorimetry, Differential Scanning | 1 | 2009 | 3 | 0.020 |
Why?
|
| Anions | 1 | 2009 | 15 | 0.020 |
Why?
|
| Freezing | 1 | 2009 | 21 | 0.020 |
Why?
|
| Drug Compounding | 1 | 2009 | 30 | 0.020 |
Why?
|
| Umbilical Cord | 1 | 2009 | 35 | 0.020 |
Why?
|
| Platelet Activation | 1 | 2009 | 54 | 0.020 |
Why?
|
| Particle Size | 1 | 2009 | 101 | 0.020 |
Why?
|
| Cell Death | 1 | 2009 | 118 | 0.020 |
Why?
|
| Animal Structures | 1 | 2007 | 2 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2007 | 118 | 0.020 |
Why?
|
| Sepsis | 1 | 2007 | 84 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2009 | 362 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2012 | 2384 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2007 | 194 | 0.020 |
Why?
|
| Kinetin | 1 | 2000 | 1 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2000 | 23 | 0.010 |
Why?
|
| Purines | 1 | 2000 | 17 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2000 | 267 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2000 | 155 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2000 | 250 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2000 | 158 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2000 | 402 | 0.010 |
Why?
|